T Cell Receptor Alpha-Joining 15: A Protein Regulating T Cell Activity

Target Name: TRAJ15

NCBI ID: G28740

TRAJ15

Other Name(s): T cell receptor alpha joining 15

T Cell Receptor Alpha-Joining 15: A Protein Regulating T Cell Activity

T cell receptor alpha-joining 15 (TRAJ15) is a protein that is expressed in the T cells, a type of white blood cell that plays a crucial role in the immune system. T cells are responsible for detecting and responding to foreign substances in the body, and their activity is regulated by the T cell receptor alpha-joining 15 protein.

The T cell receptor alpha-joining 15 protein is a transmembrane protein that is composed of two extracellular domains and an intracellular domain. The intracellular domain is responsible for interacting with the T cell receptor alpha-joining 15 protein, which is a critical receptor that is expressed in T cells.

The T cell receptor alpha-joining 15 protein is involved in the regulation of T cell activity, including the process of apoptosis, which is the process by which cells are programmed to die. During apoptosis, the T cell receptor alpha-joining 15 protein helps to induce the death of the T cells.

In addition to its role in regulating T cell activity, the T cell receptor alpha-joining 15 protein is also a potential drug target. Studies have shown that the T cell receptor alpha-joining 15 protein can be targeted by small molecules, such as those that inhibit the activity of the protein.

One way to target the T cell receptor alpha-joining 15 protein is through the use of small molecules that inhibit the activity of the protein's intracellular domain. These small molecules can be administered to T cells, either alone or in combination with other treatments.

Another approach to targeting the T cell receptor alpha-joining 15 protein is through the use of antibodies that are designed to bind to the protein. These antibodies can be used to treat T cells, either alone or in combination with other treatments.

In addition to its potential as a drug target, the T cell receptor alpha-joining 15 protein is also a potential biomarker. Studies have shown that the T cell receptor alpha-joining 15 protein can be used as a marker for the diagnosis and monitoring of certain types of cancer, such as breast cancer and colorectal cancer.

Overall, the T cell receptor alpha-joining 15 protein is a protein that is involved in the regulation of T cell activity and has the potential to be a drug target or biomarker. Further research is needed to fully understand the role of this protein in the immune system and its potential as a therapeutic agent.

Protein Name: T Cell Receptor Alpha Joining 15

The "TRAJ15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRAJ15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets